Koss (KOSS)

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement, and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins, and protein complexes.

Company profile

Ticker

KOSS

Exchange

NASDAQ

Website

www.koss.com

CEO

Michael J. Koss

Incorporated

Delaware

Location

Wisconsin

Fiscal year end

Jun 30

Sector

Manufacturing > Audio and Video Equipment Manufacturing

Industry (SIC)

Household Audio & Video Equipment

Knowles • Vizio Holding • Sonos • Universal Electronics • Arlo • Emerson Radio • Genasys • Kemiao Garment Holding • Avra • Integrated Media Technology Limited ...

SEC CIK

0000056701

Corporate docs

Articles of Incorporation & Bylaws

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Koss U.K. Limited • Koss B.V. ...

IRS number

391168275

KOSS stock data

1M 1Y 5Y

News

From Benzinga Pro

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session

1 Aug 22

Gainers TravelCenters Of America (NASDAQ:TA) stock moved upwards by 10.7% to $47.0 during Monday's after-market session. The market value of their outstanding shares is at $697.3 million. As per the press release, Q2 earnings came out today.

12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session

1 Aug 22

Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday

27 Jul 22

Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.

11 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session

26 Jul 22

Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session

26 Jul 22

Press releases

From Benzinga Pro

Thinking about buying stock in Redbox, Liberty Energy, Shell, Livent, or Koss Corp?

26 Jul 22

NEW YORK, July 26, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RDBX, LBRT, SHLX, LTHM, and KOSS.

Calendar

5 May 22

12 Aug 22

30 Jun 23

Financial summary

Financial statements Chart KOSS financial data

Quarter (USD)	Mar 22	Dec 21	Sep 21	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Jun 21	Jun 20	Jun 19	Jun 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	9.49M	9.49M	9.49M	9.49M	9.49M	9.49M
Cash burn (monthly)	(no burn)	(no burn)	(no burn)	(no burn)	97.39K	(no burn)
Cash used (since last report)	n/a	n/a	n/a	n/a	428.96K	n/a
Cash remaining	n/a	n/a	n/a	n/a	9.06M	n/a
Runway (months of cash)	n/a	n/a	n/a	n/a	93.0	n/a

Beta Read what these cash burn values mean

Financial data from Koss earnings reports.

Recent insider trades

KOSS insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
2 Jun 22	William Jesse Sweasy	Common Stock	Buy	Acquire P	No	No	7.3	2,847	20.78K	20,000
1 Jun 22	William Jesse Sweasy	Common Stock	Buy	Acquire P	No	No	6.96	17,153	119.38K	17,153
23 Mar 22	Koss John C JR	Common Stock		Dispose Z	Yes	No	0	983,800	0	0
23 Mar 22	Koss John C JR	Common Stock		Dispose Z	Yes	No	0	707,949	0	0
23 Mar 22	Koss John C JR	Common Stock		Dispose Z	Yes	No	0	1,000,885	0	0
23 Mar 22	Koss Michael J	Common Stock		Acquire Z	Yes	No	0	2,696,634	0	2,696,634
23 Mar 22	Koss Michael J	Common Stock		Dispose Z	Yes	No	0	983,800	0	0
23 Mar 22	Koss Michael J	Common Stock		Dispose Z	Yes	No	0	707,949	0	0
23 Mar 22	Koss Michael J	Common Stock		Dispose Z	Yes	No	0	1,000,885	0	0
23 Mar 22	KFT	Common Stock		Dispose Z	No	No	0	983,800	0	0

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

KOSS institutional ownership history Ownership history

10.9% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1	25	-96.0%
Opened positions	0	6	EXIT
Closed positions	24	6	+300.0%
Increased positions	0	8	EXIT
Reduced positions	0	8	EXIT

13F shares	Current	Prev Q	Change
Total value	35.03M	65.78M	-46.7%
Total shares	1M	3.17M	-68.5%
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Koss Michael J Jr	1M	$35.03M	0.0%
Koss Michael J	0	$0	EXIT

Largest transactions	Bought/sold	Change
Koss Michael J	-1M	EXIT
CIBC Private Wealth	-546.53K	EXIT
Vanguard	-183.93K	EXIT
Dimensional Fund Advisors	-154.55K	EXIT
BLK Blackrock	-61.6K	EXIT
Geode Capital Management	-52.85K	EXIT
Cresset Asset Management	-40K	EXIT
MS Morgan Stanley	-33.8K	EXIT
Jane Street	-33.34K	EXIT
STT State Street	-17.17K	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: added, blended, Chinese, conflict, declared, dedicated, disgorgement, distributor, driver, drop, dropped, ease, Eastern, environment, fewer, humanitarian, imposed, inflationary, invasion, largest, linger, minimal, minimize, moderate, Omicron, ongoing, Order, packaging, partner, persistence, political, receipt, refuge, repeat, resurgence, Russia, seeking, subvariant, suit, suspended, translated, transportation, trial, Ukraine, varied, Western, wholly

Removed: effect, experiencing, home, implement, online, routing, significantly, studying

From filing 10-Q 2022 Q3

Financial reports

View all